atazanavir sulfate has been researched along with Hyperlipemia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabrera, F; Isasti, G; Moreno, T; Palacios, R; Pérez, I; Santos, J | 1 |
| Aoyama, H; Fukushima, K; Kobuchi, S; Mizuhara, K; Shibata, M; Sugioka, N; Takada, K; Uchisako, R | 1 |
| Andrade Neto, JL; Donnelly, A; González-García, J; Grinsztejn, B; Ledesma, E; McGrath, D; Molina, JM; Phiri, P; Sension, M; Zavala, I | 1 |
| Ciurlionis, R; Degoey, DA; Kempf, DJ; Klein, LL; Marsh, K; Randolph, JT; Spear, B; Waring, JF | 1 |
| Chen, MY; Ho, MW; Hsieh, SM; Hung, CC; Lin, HH; Lin, YH; Lu, CL; Sheng, WH; Wang, NC; Wong, WW | 1 |
| Cahn, P; Giordano, M; Kelleher, T; Mancini, M; Murphy, R; Pantaleo, G; Phanuphak, P; Pokrovskiy, V; Rozenbaum, W; Sension, M; Wood, R | 1 |
| Bini, T; Bongiovanni, M; Chiesa, E; Codemo, R; Gervasoni, C; Gornati, R; Ortu, M; Piolini, R; Pisacreta, M; Porretta, T; Tordato, F; Trovati, S | 1 |
| Coupal, L; Gilmore, N; Grover, SA; Mukherjee, J | 1 |
| Behrens, GM; Castro-Frenzel, B; Christensen, S; Esser, S; Fätkenheuer, G; Lubach-Ruitman, M; Möbius, U; Rump, JA; Schmidt, RE; Stoll, M; Voigt, E | 1 |
| Scott, LJ; Swainston Harrison, T | 1 |
| Coleman, CI; White, CM | 1 |
| Bracciale, L; Cauda, R; Colafigli, M; De Luca, A; Di Giambenedetto, S; Tamburrini, E | 1 |
1 review(s) available for atazanavir sulfate and Hyperlipemia
| Article | Year |
|---|---|
Atazanavir: a review of its use in the management of HIV infection.
Topics: Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperlipidemias; In Vitro Techniques; Insulin Resistance; Oligopeptides; Protease Inhibitors; Pyridines | 2005 |
5 trial(s) available for atazanavir sulfate and Hyperlipemia
| Article | Year |
|---|---|
Improvement in lipid profiles in antiretroviral-experienced HIV-positive patients with hyperlipidemia after a switch to unboosted atazanavir.
Topics: Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; Cholesterol, LDL; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Hyperlipidemias; Male; Middle Aged; Oligopeptides; Pyridines | 2009 |
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Chi-Square Distribution; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Male; Oligopeptides; Prospective Studies; Pyridines; Treatment Outcome; Triglycerides | 2011 |
Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cholesterol, LDL; Female; HIV Infections; Humans; Hyperlipidemias; Lamivudine; Lipids; Male; Nelfinavir; Oligopeptides; Pyridines; RNA, Viral; Safety; Stavudine; Time Factors; Triglycerides | 2004 |
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Female; HIV Infections; Humans; Hyperlipidemias; Lamivudine; Life Expectancy; Male; Markov Chains; Middle Aged; Nelfinavir; Oligopeptides; Pyridines; Risk Factors; Stavudine | 2005 |
Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cohort Studies; Female; HIV Infections; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Oligopeptides; Pyridines; Triglycerides | 2005 |
7 other study(ies) available for atazanavir sulfate and Hyperlipemia
| Article | Year |
|---|---|
Prevalence and factors associated with a prolonged QTc interval in a cohort of asymptomatic HIV-infected patients.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Electrocardiography; Female; Heart Rate; HIV Infections; Humans; Hyperlipidemias; Long QT Syndrome; Male; Middle Aged; Oligopeptides; Prevalence; Pyridines; Risk Factors; Surveys and Questionnaires; Viral Load | 2013 |
[Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Clinical Trials as Topic; HIV Protease Inhibitors; Humans; Hyperlipidemias; Oligopeptides; Pyridines; Triglycerides; Viral Load | 2008 |
Effect of serum lipids on the pharmacokinetics of atazanavir in hyperlipidemic rats.
Topics: Animals; Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Half-Life; Hyperlipidemias; Male; Oligopeptides; Protein Binding; Pyridines; Rats; Rats, Wistar | 2009 |
Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia.
Topics: Animals; Atazanavir Sulfate; Carbamates; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Furans; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; HIV Protease Inhibitors; Hyperlipidemias; Male; Oligonucleotide Array Sequence Analysis; Oligopeptides; Proteasome Endopeptidase Complex; Pyridines; Rats; Rats, Sprague-Dawley; Ritonavir; Sulfonamides | 2010 |
Pseudoaneurysm of the femoral artery in a HIV-infected man.
Topics: Aneurysm, False; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Femoral Artery; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Male; Middle Aged; Oligopeptides; Postoperative Hemorrhage; Pyridines; Streptococcal Infections; Ultrasonography, Doppler, Color; Vascular Surgical Procedures | 2004 |
A comparison of different protease inhibitors on coronary heart disease risk.
Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Clinical Trials as Topic; Coronary Disease; HIV Protease Inhibitors; HIV Seropositivity; Humans; Hyperlipidemias; Nelfinavir; Oligopeptides; Pyridines; Risk Factors | 2007 |
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Male; Middle Aged; Oligopeptides; Pyridines; Risk Factors | 2008 |